Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections.
Andrea DavisAlexandra M StevensJulienne BrackettLucila MarquezCatherine E FosterHannah E SauerJudith R CampbellPublished in: Pediatric blood & cancer (2022)
Following implementation of a levofloxacin prophylaxis guideline, we observed a significant decrease in BSIs due to Gram-negative rods and NHSN CLABSIs. Vigilant monitoring of outcomes post guideline implementation is critical to track emergence of resistant organisms.